Edward Miller - 19 Jan 2023 Form 4 Insider Report for Allovir, Inc. (KLRS)

Role: General Counsel
Signature: /s/ Brett Hagen, as Attorney-in-Fact
Issuer symbol: KLRS
Transactions as of: 19 Jan 2023
Net transactions value: -$13,101
Form type: 4
Filing time: 23 Jan 2023, 18:00:21 UTC
Previous filing: 16 Nov 2022
Next filing: 03 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALVR	Common Stock	Gift	$0	-98,346	-39%	$0.000000	151,031	02 Dec 2022	Direct	F1
transaction	ALVR	Common Stock	Gift	$0	+98,346	+52%	$0.000000	288,799	02 Dec 2022	See footnote	F1, F2
transaction	ALVR	Common Stock	Sale	$10,318	-2,032	-1.3%	$5.08	148,999	19 Jan 2023	Direct	F3, F4
transaction	ALVR	Common Stock	Sale	$2,783	-541	-0.36%	$5.14	148,458	20 Jan 2023	Direct	F3, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On December 2, 2022, the Reporting Person transferred 98,346 shares to The Miller Family 2019 Irrevocable Dynasty Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F2	Shares held by The Miller Family 2019 Irrevocable Dynasty Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F3	Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and intended to qualify under Rule 10b5-1.
F4	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.94 to $5.19. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F5	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.05 to $5.22. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.